One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient

Supportive Care in Cancer

Volumn 17, Issue 1, 2009, Pages 23-32

  Enblom, Anna ^a,f,g   Bergius Axelsson, Beata ^c   Steineck, Gunnar ^d,e   Hammar, Mats ^a   Börjeson, Sussanne ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Vardal Institute   (Sweden)

^g IMH Omvårdnad ^*  (Sweden)

Author keywords

Antiemetics; Daily living; Quality of life; Risk factors; Vomiting

Indexed keywords

ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEROTONIN 3 ANTAGONIST;

ACUPUNCTURE; ADULT; AGED; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DESCRIPTIVE RESEARCH; FEMALE; FUNCTIONAL STATUS; HUMAN; MALE; NAUSEA; NEOPLASM; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION FIELD; RADIATION INDUCED EMESIS; RADIATION INDUCED NAUSEA; RISK ASSESSMENT; RISK FACTOR; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PATIENT SATISFACTION; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; RISK FACTORS; VOMITING; YOUNG ADULT;

EID: 57949084679     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0445-x     Document Type: Article

References (52)

1. M Aapro P Blower 2005 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents? Cancer 104 1 1 18
2. G Abdelsayed 2007 Management of radiation-induced nausea and vomiting Exp Hematol 35 4 suppl 1 34 36
3. E Ballatori F Roila B Ruggeri M Betti S Sarti G Soru G Cruciani M Di Maio B Andrea RR Deuson 2007 The impact of chemotherapy-induced nausea and vomiting on health-related quality of life Support Care Cancer 15 2 179 185
4. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G (1999) Vaginal changes and sexuality in women with a history of cervical cancer. New Engl J Med 6:340(18):1383-1389
5. J Bernhard M Sullivan C Hürny AS Coates CM Rudenstam 2001 Clinical relevance of single item quality of life indicators in cancer clinical trials Br J Cancer 84 9 1156 1165
6. 3 antagonists Br J Cancer 76 8 1055 1061
7. JG Boogaerts E Vanacker L Seidel A Albert FM Bardiau 2000 Assessment of postoperative nausea using a visual analogue scale Acta Anaesthesiol Scand 44 4 470 474
8. S Bosnjak S Radulović Z Nesković-Konstantinović L Mitrović 2000 Patient statement of satisfaction with antiemetic treatment is related to quality of life Am J Clin Oncol 23 6 575 578
9. K Bremer 1994 Individually risk-adapted antiemetic step therapy Dtsch Med Wochenschr 119 16 598 604
10. S Börjeson TJ Hursti C Peterson M Fredrikson CJ Fürst E Avall-Lundqvist G Steineck 1997 Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale Cancer Nurs 20 4 260 266
11. S Börjeson TJ Hursti C Tishelman C Peterson G Steineck 2002 Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being J Pain Symptom Manage 24 3 345 358
12. HM Davey AL Barratt PN Butow JJ Deeks 2007 A one-item question with a Likert or Visual Analogue Scale adequately measured current anxiety J Clin Epidemiol 60 4 356 360
13. KM Doherty 1999 Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy Clin J Oncol Nurs 3 3 113 119
14. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe J, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G (2006) Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. April 19 (2):CD002285
15. P Feyer O Titlbach J Wilkinson V Budach 1996 Gastrointestinal reactions in radiotherapy (abstract 100) Support Care Cancer 4 249
16. PC Feyer AL Stewart OJ Titlbach 1998 Aetiology and prevention of emesis induced by radiotherapy Support Care Cancer 6 3 253 260
17. PCh Feyer E Maranzano A Molassiotis RA Clark-Snow F Roila D Warr I Olver 2005 Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines Support Care Cancer 13 2 122 128
18. J Foubert G Vaessen 2005 Nausea: the neglected symptom? Eur J Oncol Nurs 9 1 21 32
19. Goldsmith B (2003) Antiemetic patterns of care for radiotherapy induced nausea and vomiting (Abstract 2975). Am Soc Clin Oncol - ASCO 22:740
20. IR Gough CM Furnival L Schilder W Grove 1983 Assessment of the quality of life of patients with advanced cancer Eur J Cancer Clin Oncol 19 8 1161 1165
21. RJ Gralla D Osoba MG Kris P Kirkbride PJ Hesketh LW Chinnery R Clark-Snow DP Gill S Groshen S Grunberg JM Koeller GR Morrow EA Perez JH Silber DG Pfister 1999 Recommendations for guidelines for the use of antiemetics: evidence-based, clinical practice guidelines J Clin Oncol 17 9 2971 2994
22. AM Griffin PN Butow AS Coates AM Childs PM Ellis SM Dunn MH Tattersall 1996 On the receiving end. V: patient perceptions of the side-effects of cancer chemotherapy in 1993 Ann Oncol 7 2 189 195
23. JC Horiot M Aapro 2004 Treatment implications for radiation-induced nausea and vomiting in specific patient groups Eur J Cancer 40 7 979 987
24. C Hürny J Bernhard A Coates HF Peterson M Castiglione-Gertsch RD Gelber CM Rudenstam J Collins J Lindtner A Goldhirsch HJ Senn 1996 Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial Med Care 34 3 234 248
25. IGARR (the Italian Group for Antiemetic Research in Radiotherapy) 1999 Radiation-induced emesis: a prospective observational multicenter Italian trial Int J Radiat Oncol Biol Phys 44 3 619 625
26. P Kirkbride A Bezjak J Pater B Zee MJ Palmer R Wong P Cross S Gulavita P Blood A Sun G Dundas PK Ganguly J Lim AD Chowdhury SE Kumar AR Dar 2000 Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group Phase III Study J Clin Oncol 18 9 1960 1966
27. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24(18):2932-2947
28. R Lanciano DM Sherman J Michalski AJ Preston K Yocom C Friedman 2001 The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy Cancer Invest 19 763 772
29. R Lindeboom M Vermeulen R Holman RJ De Haan 2003 Activities of daily living instruments: optimizing scales for neurologic assessments Neurology 60 5 738 742
30. CM Lindley JD Hirsch CV O'Neill MC Transau CS Gilbert JT Osterhaus 1992 Quality of life consequences of chemotherapy-induced emesis Qual Life Res 1 5 331 340
31. E Maranzano PCh Feyer A Molassiotis R Rossi RA Clark-Snow I Olver D Warr C Schiavone F Roila Participants in the Perugia Consensus Conference 2004 2005 Evidence-based recommendations for the use of antiemetics in radiotherapy Radiother Oncol 76 3 227 233
32. CG Martin EB Rubenstein LS Elting YJ Kim D Osoba 2003 Measuring chemotherapy-induced nausea and emesis Cancer 98 3 645 655
33. AR Martin JD Pearson B Cai M Elmer K Horgan C Lindley 2003 Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall Support Care Cancer 11 8 522 527
34. AR Martin AD Carides JD Pearson K Horgan M Elmer C Schmidt B Cai SP Chawla SM Grunberg 2003 Functional relevance of antiemetic control: experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant Eur J Cancer 39 10 1395 1401
35. The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) 1998 Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia Consensus Conference Ann Oncol 9 8 811 819
36. K Mystakidou E Katsouda A Linou E Parpa V Kouloulias V Nikolaou L Vlahos 2006 Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: a prospective randomized open label study in cancer patients Med Oncol 23 2 251 262
37. RK Wong N Paul K Ding M Whitehead M Brundage A Fyles D Wilke A Nabid A Fortin D Wilson M McKenzie I Ackerman L Souhami P Chabot J Pater National Cancer Institute of Canada Clinical Trials Group (SC19) 2006 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19) J Clin Oncol 24 21 3458 3464
38. E Onelöv G Steineck U Nyberg A Hauksdóttir U Kreicbergs L Henningsohn K Bergmark U Valdimarsdóttir 2007 Measuring anxiety and depression in the oncology setting using visual-digital scales Acta Oncol 46 6 810 816
39. D Osoba B Zee D Warr J Latreille L Kaizer J Pater 1997 Effect of postchemotherapy nausea and vomiting on health-related quality of life The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Trials Group Support Care Cancer 5 4 307 313
40. TJ Priestman JT Roberts H Lucraft CH Collis M Adams 1990 Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation Clin Oncol 2 71 75
41. MA Richardson T Sanders JL Palmer A Greisinger SE Singletary 2000 Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology J Clin Oncol 18 13 2505 2514
42. F Roila G Ciccarese MA Palladino V De Angelis 1998 Prevention of radiotherapy-induced emesis Tumori 84 2 274 278
43. JA Roscoe GR Morrow JT Hickok RM Stern 2000 Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices J Pain Symptom Manage 20 2 113 121
44. FM Schnell 2003 Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control Oncologist 8 2 187 198
45. JA Sloan MH Frost R Berzon A Dueck G Guyatt C Moinpour M Sprangers C Ferrans D Cella Clinical Significance Consensus Meeting Group 2006 The clinical significance of quality of life assessments in oncology: a summary for clinicians Support Care Cancer 14 10 988 998
46. TR Spitzer CJ Friedman W Bushnell SR Frankel J Raschko 2000 Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation Bone Marrow Transplant 26 2 203 210
47. M Sprangers 2002 Quality-of-life assessment in oncology. Achievements and challenges Acta Oncol 41 3 229 237
48. G Steineck K Bergmark L Henningsohn M al-Abany PW Dickman A Helgason 2002 Symptom documentation in cancer survivors as a basis for therapy modifications Acta Oncologica 41 3 244 252
49. G Steineck H Hunt J Adolfsson 2006 A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods Acta Oncol 45 4 421 429
50. CC Sun DC Bodurka ML Donato EB Rubenstein CL Borden K Basen-Engquist MF Munsell JJ Kavanagh DM Gershenson 2002 Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynaecol Oncol 87 1 118 128
51. AJ Sykes AE Kiltie AL Stewart 1997 Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy Support Care Cancer 5 6 500 503
52. G Tonini B Vincenzi D Santini A La Cesa E Finolezzi N Onori R D'Angelillo A Baldi L Trodella 2003 Prevention of radiotherapy-induced emesis J Exp Clin Cancer Res 22 1 17 22